What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France.
about
What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France.
description
2019 nî lūn-bûn
@nan
2019年の論文
@ja
2019年学术文章
@wuu
2019年学术文章
@zh
2019年学术文章
@zh-cn
2019年学术文章
@zh-hans
2019年学术文章
@zh-my
2019年学术文章
@zh-sg
2019年學術文章
@yue
2019年學術文章
@zh-hant
name
What is the clinical impact of ...... prospective survey in France.
@en
What is the clinical impact of ...... prospective survey in France.
@nl
type
label
What is the clinical impact of ...... prospective survey in France.
@en
What is the clinical impact of ...... prospective survey in France.
@nl
prefLabel
What is the clinical impact of ...... prospective survey in France.
@en
What is the clinical impact of ...... prospective survey in France.
@nl
P2093
P50
P1433
P1476
What is the clinical impact of ...... e prospective survey in France
@en
P2093
Alain Jager
Anne-Cécile Troussière
Audrey Gabelle
Bernard Croisile
Carole Miguet-Alfonsi
Claire Paquet
David Wallon
Didier Hannequin
Elodie Bouaziz-Amar
Emilie Beaufils
P304
P356
10.1136/BMJOPEN-2018-026380
P577
2019-05-30T00:00:00Z